Clinical Trials Logo

Crush Injury clinical trials

View clinical trials related to Crush Injury.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06003166 Not yet recruiting - Clinical trials for Peripheral Nerve Injury

4-AP Peripheral Nerve Crossover Trial

Start date: April 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the role of single dose 4-aminopyridine (4-AP) on the diagnosis of severing vs non-severing nerve injury after peripheral nerve traction and/or crush injury. The investigational treatment will be used to test the hypothesis that 4-aminopyridine can speed the determination of nerve continuity after peripheral nerve traction and/or crush injuries allowing the identification of incomplete injuries earlier than standard electrodiagnostic (EDX) and clinical assessment. Participants will be randomized to one of two groups to determine the order of treatment they receive (drug and placebo vs placebo and drug). Participants will undergo baseline testing for nerve assessment, receive either drug or placebo based on randomization and undergo hourly sensory and motor evaluation, EDX testing and serum 4AP levels for three hours after dosing. Participants will then repeat this with the crossover arm.